Get the Stockscreener App
22.97
4.34%
-1.1417
Vor Biopharma Inc stock is traded at $22.97, with a volume of 163.43K.
It is down -4.34% in the last 24 hours and down -38.43% over the past month.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
See More
Previous Close:
$24.11
Open:
$24.16
24h Volume:
163.43K
Relative Volume:
0.47
Market Cap:
$165.25M
Revenue:
-
Net Income/Loss:
$-112.46M
P/E Ratio:
-14.01
EPS:
-1.64
Net Cash Flow:
$-99.89M
1W Performance:
-18.01%
1M Performance:
-38.43%
6M Performance:
+74.36%
1Y Performance:
+43.29%
1-Day Range:
$22.56
$24.50
1-Week Range:
$22.56
$28.66
52-Week Range:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma Inc
Sector
Industry
Phone
617-655-6580
Address
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Compare VOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
23.06 | 165.25M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.28 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.20 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.06 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-25 | Upgrade | Stifel | Hold → Buy |
| Jun-30-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-26-22 | Initiated | Wedbush | Outperform |
| Apr-27-22 | Initiated | Goldman | Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-21 | Initiated | Robert W. Baird | Outperform |
| Dec-02-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Mar-03-21 | Initiated | Evercore ISI | Outperform |
| Mar-02-21 | Initiated | Goldman | Sell |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Vor Biopharma Inc Stock (VOR) Latest News
How institutional ownership impacts Vor Biopharma Inc. stock2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
Vor Biopharma Inc. stock retracement – recovery analysisWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com
Why Vor Biopharma Inc. stock could benefit from AI revolution2025 Short Interest & Fast Moving Trade Plans - newser.com
Will Vor Biopharma Inc. stock gain from government policiesEarnings Overview Report & Daily Stock Trend Reports - newser.com
Vor Biopharma Appoints New Chief Medical Officer - TipRanks
Vor Bio Appoints Jeremy Sokolove, M.D. as Chief Medical Officer - GlobeNewswire
Can a trend reversal in Vor Biopharma Inc. lead to recoveryMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
Can Vor Biopharma Inc. stock beat analyst upgradesPortfolio Performance Report & Reliable Intraday Trade Plans - newser.com
Technical signs of recovery in Vor Biopharma Inc.Weekly Trade Summary & Daily Volume Surge Signals - newser.com
Risk adjusted return profile for Vor Biopharma Inc. analyzedJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Forecasting Vor Biopharma Inc. price range with options dataMarket Trend Review & Risk Managed Investment Strategies - newser.com
Vor Biopharma Inc. stock volume spike explainedVolume Spike & Community Trade Idea Sharing - newser.com
How currency fluctuations impact Vor Biopharma Inc. stockQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Long term hold vs stop loss in Vor Biopharma Inc.Weekly Trend Recap & Fast Entry Momentum Alerts - newser.com
Applying big data sentiment scoring on Vor Biopharma Inc.Day Trade & Weekly Market Pulse Updates - newser.com
Vor Biopharma Inc. stock chart pattern explainedJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com
Using data models to predict Vor Biopharma Inc. stock movementWeekly Risk Report & Weekly Stock Performance Updates - newser.com
Pattern recognition hints at Vor Biopharma Inc. upsideQuarterly Portfolio Report & Long-Term Safe Return Strategies - newser.com
Published on: 2025-11-02 01:05:22 - newser.com
Q3 EPS Estimates for Vor Biopharma Boosted by HC Wainwright - MarketBeat
Combining price and volume data for Vor Biopharma Inc.Weekly Loss Report & Weekly Watchlist of Top Performers - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsCPI Data & Daily Profit Maximizing Tips - newser.com
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 124,311 Shares - MarketBeat
Vor Biopharma (NASDAQ:VOR) Director Ra Capital Management, L.P. Sells 251,518 Shares - MarketBeat
RA CAPITAL MANAGEMENT, L.P. Reduces Stake in Vor Biopharma Inc. - GuruFocus
Vor Bio (NASDAQ: VOR) issues inducement equity to 20 new hires at $30.22 per share - Stock Titan
FY2028 EPS Estimates for Vor Biopharma Decreased by Analyst - MarketBeat
Published on: 2025-10-31 05:21:03 - newser.com
Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million By Investing.com - Investing.com Nigeria
Ra capital sells Vor Biopharma (VOR) shares worth $10.3 million - Investing.com
VOR Form 4: RA Capital reports multi-day insider stock sales - Stock Titan
Vor Biopharma Inc. (VOR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Vor Biopharma (NASDAQ:VOR) Price Target Raised to $52.00 - MarketBeat
Vor Biopharma Inc Stock (VOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vor Biopharma Inc Stock (VOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 28 '25 |
Sale |
27.42 |
124,311 |
3,408,230 |
1,055,749 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 30 '25 |
Sale |
25.12 |
24,579 |
617,424 |
779,652 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 27 '25 |
Sale |
28.12 |
90,941 |
2,557,261 |
1,180,060 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 23 '25 |
Sale |
28.01 |
76,880 |
2,153,409 |
1,324,346 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 24 '25 |
Sale |
28.01 |
53,345 |
1,494,193 |
1,271,001 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 20 '25 |
Sale |
29.67 |
92,023 |
2,730,483 |
0 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 21 '25 |
Sale |
28.11 |
25,027 |
703,509 |
1,401,226 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 17 '25 |
Sale |
30.25 |
25,717 |
777,987 |
1,178,725 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 20 '25 |
Sale |
30.05 |
11,616 |
349,101 |
1,167,109 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 21 '25 |
Sale |
30.07 |
200 |
6,015 |
1,166,909 |
0.15%
1.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):